138 related articles for article (PubMed ID: 2161935)
1. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow CA; Reardon IM; Chaudhary VK; Fryling CM; Pastan I; Fitzgerald DJ
J Virol; 1990 Jul; 64(7):3157-61. PubMed ID: 2161935
[TBL] [Abstract][Full Text] [Related]
2. Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; FitzGerald DJ; Chaudhary VK; Pastan I; Heinrikson RL
J Biol Chem; 1990 Jan; 265(1):408-13. PubMed ID: 2104621
[TBL] [Abstract][Full Text] [Related]
3. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
4. Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV.
Nashed NT; Louis JM; Sayer JM; Wondrak EM; Mora PT; Oroszlan S; Jerina DM
Biochem Biophys Res Commun; 1989 Sep; 163(2):1079-85. PubMed ID: 2551268
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
7. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.
Bagossi P; Sperka T; Fehér A; Kádas J; Zahuczky G; Miklóssy G; Boross P; Tözsér J
J Virol; 2005 Apr; 79(7):4213-8. PubMed ID: 15767422
[TBL] [Abstract][Full Text] [Related]
8. Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates.
Kotler M; Danho W; Katz RA; Leis J; Skalka AM
J Biol Chem; 1989 Feb; 264(6):3428-35. PubMed ID: 2536748
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides as substrates and inhibitors of a retroviral protease.
Kotler M; Katz RA; Danho W; Leis J; Skalka AM
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4185-9. PubMed ID: 2837759
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
11. Specificity studies on retroviral proteinase from myeloblastosis-associated virus.
Strop P; Konvalinka J; Stys D; Pavlickova L; Blaha I; Velek J; Travnicek M; Kostka V; Sedlacek J
Biochemistry; 1991 Apr; 30(14):3437-43. PubMed ID: 1849425
[TBL] [Abstract][Full Text] [Related]
12. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
13. In vitro cleavage of avian retrovirus gag proteins by viral protease p15.
Vogt VM; Wight A; Eisenman R
Virology; 1979 Oct; 98(1):154-67. PubMed ID: 90424
[No Abstract] [Full Text] [Related]
14. Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
Eizert H; Bander P; Bagossi P; Sperka T; Miklóssy G; Boross P; Weber IT; Tözsér J
J Virol; 2008 Oct; 82(20):10111-7. PubMed ID: 18701588
[TBL] [Abstract][Full Text] [Related]
15. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
16. Amino acid sequence analysis of reverse transcriptase subunits from avian myeloblastosis virus.
Copeland TD; Grandgenett DP; Oroszlan S
J Virol; 1980 Oct; 36(1):115-9. PubMed ID: 6160262
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases.
Tözsér J; Bagossi P; Weber IT; Copeland TD; Oroszlan S
J Biol Chem; 1996 Mar; 271(12):6781-8. PubMed ID: 8636100
[TBL] [Abstract][Full Text] [Related]
18. Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease.
Wu JC; Carr SF; Jarnagin K; Kirsher S; Barnett J; Chow J; Chan HW; Chen MS; Medzihradszky D; Yamashiro D
Arch Biochem Biophys; 1990 Mar; 277(2):306-11. PubMed ID: 2178555
[TBL] [Abstract][Full Text] [Related]
19. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
[TBL] [Abstract][Full Text] [Related]
20. Amino acid sequence of p15 from avian myeloblastosis virus complex.
Sauer RT; Allen DW; Niall HD
Biochemistry; 1981 Jun; 20(13):3784-91. PubMed ID: 6268146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
